- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06466213
Acute Effects of Three Different Types Single Leg Exercise in Copd (COPD)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute Effects of Three Different Types Single Leg Exercise in Copd
single bout high intensity interval training
single bout continuous exercise training single bout resistance training
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ankara
-
Ankara, Ankara, Turkey (Türkiye)
- Elif Kocaaga
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- COPD patients that applied to physiotherapy
- cooperate to test
- no severe ortopedical and neurological disease no severe cardiovascular disease volunteer to study
Exclusion Criteria:
- have an acute exacerbation
- hypoxemia [PaO2] <55 mmHg
- no cooperated to test no volunteer to study having ortophedical and neurological diesase that affecting of tests having severe cardiovascular disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: single session one leg exercise intervantion in COPD
first session: single session leg Continuous exercise intervantion will be applied to COPD. Unilaterally single leg continuous exercise will be performed as only one session second session : single session leg high intensity interval exercise intervantion will be applied to COPD. Unilaterally single leg hııt exercise will be performed as only one session third sessionsingle session leg resistance exercise intervantion will be applied to COPD. Respirocally leg strength (knee extantion ) exercise will be performed |
cycle exercise includes single leg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
six minute walk test
Time Frame: beginning, day 1
|
six minute walk test in meter
|
beginning, day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cardiopulmonary exercise test
Time Frame: beginning, day 2
|
VO2 max will be recorded as ml/kg/min will be recorded from incremental cycle cpet test
|
beginning, day 2
|
|
single leg extremity test
Time Frame: beginning, day 3
|
VO2 max will be recorded as ml/kg/min will be recorded from incremental cycle cpet test
|
beginning, day 3
|
|
lung function
Time Frame: beginning, day 1
|
FVC in % , FEV1 in %, FEV1/FVC ratio, PEF in % and FEF 25-75 in %
|
beginning, day 1
|
|
muscle strength (isometric)
Time Frame: beginning day 1
|
quadriceps isometric muscle strength will be recorded as kilogram
|
beginning day 1
|
|
muscle strength (10 repeated max)
Time Frame: beginning, day 1
|
quadriceps 10 repeated max muscle strength will be recorded as kilogram
|
beginning, day 1
|
|
continous exercise acute (single leg)
Time Frame: beginning day 4
|
VO2 max will be recorded as ml/kg/min will be performed from incremental cycle exercise at single session
|
beginning day 4
|
|
high intensity interval training acute exercise (single leg)
Time Frame: beginning day 5
|
VO2 max will be recorded as ml/kg/min will be performed from incremental cycle exercise at single session
|
beginning day 5
|
|
strength training acute exercise (single leg)
Time Frame: beginning day 4,5,6
|
VO2 max will be recorded as ml/kg/min will be performed from incremental cycle exercise at single session
|
beginning day 4,5,6
|
|
muscle oxygenation
Time Frame: beginning day 4,5,6
|
minumum muscle oxygenation level will be presented as percentage
|
beginning day 4,5,6
|
|
arterial stifness
Time Frame: beginning day 2,3, 4,5,6
|
Aıx@75 in %
|
beginning day 2,3, 4,5,6
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: elif kocaaga, ms, Hacettepe University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GO23-193
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.